Nutrition and Physical Activity in Patients With Cerebrovascular Disease
Evaluation of Skin Quality Improvement
A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion
|4||Enrolling by invitation||
Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
† Study has passed its completion date and status has not been verified in more than two years.